Related Experiment Video
Updated: Apr 7, 2026
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Molecular genetics and pathogenesis of cardiomyopathy
1Department of Molecular Pathogenesis, Medical Research Institute, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Insights
Primary cardiomyopathy, including hypertrophic (HCM) and dilated (DCM) types, stems from genetic mutations affecting cardiac muscle function. These mutations alter calcium sensitivity and sarcomere stiffness, leading to distinct disease phenotypes.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Cardiomyopathy involves cardiac muscle functional impairment from extrinsic and intrinsic factors.
- Primary cardiomyopathy arises from intrinsic factors, with hypertrophic (HCM) and dilated (DCM) cardiomyopathy as key phenotypes.
Purpose of the Study:
- To explore the genetic basis and functional alterations in primary cardiomyopathies.
- To correlate molecular changes with clinical phenotypes of HCM and DCM.
Main Methods:
- Genetic analysis to identify disease-causing genes.
- Functional studies on mutations to understand their impact on cardiac muscle mechanics.
Main Results:
- Genetic studies identified disease genes for hereditary primary cardiomyopathy.
- Mutations are linked to altered Ca(2+) sensitivity (increased in HCM, decreased in DCM) and sarcomere stiffness.
- Functional analysis reveals varied responses to metabolic stress, highlighting disease heterogeneity.
Conclusions:
- Genetic mutations in primary cardiomyopathy lead to specific functional deficits.
- Altered calcium sensitivity and sarcomere properties are key mechanisms differentiating HCM and DCM.
- Cardiomyopathy pathogenesis is heterogeneous, involving diverse molecular and functional pathways.
Abstract:
Cardiomyopathy is defined as a disease of functional impairment in the cardiac muscle and its etiology includes both extrinsic and intrinsic factors. Cardiomyopathy caused by the intrinsic factors is called as primary cardiomyopathy of which two major clinical phenotypes are hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM). Genetic approaches have revealed the disease genes for hereditary primary cardiomyopathy and functional studies have demonstrated that characteristic functional alterations induced by the disease-associated mutations are closely related to the clinical types, such that increased and decreased Ca(2+) sensitivities of muscle contraction are associated with HCM and DCM, respectively. In addition, recent studies have suggested that mutations in the Z-disc components found in HCM and DCM may result in increased and decreased stiffness of sarcomere, respectively. Moreover, functional analysis of mutations in the other components of cardiac muscle have suggested that the altered response to metabolic stresses is associated with cardiomyopathy, further indicating the heterogeneity in the etiology and pathogenesis of cardiomyopathy.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
01:25Cardiomyopathy I: Introduction and Classification
01:30Cardiomyopathy II: Dilated Cardiomyopathy
01:29Cardiomyopathy V: Interprofessional Care
01:21Myocarditis I: Introduction
01:17Pathophysiology of Heart Failure